JODI DURST: Open Payments
NPI 1942969043 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $45 |
| Corcept Therapeutics | 2 | $39 |
| Astellas Pharma US Inc | 1 | $17 |
| PFIZER INC. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: CAPLYTA, FANAPT, Korlym, Veozah, NURTEC ODT, VRAYLAR, REXULTI, Auvelity.
Industry payments across IN — which companies pay providers there.
